Back to Trades
Other4
HALOZYME THERAPEUTICS, INC.
HALO
Total Value
$3.8M
Company Information
- Company Name
- HALOZYME THERAPEUTICS, INC.
- Ticker Symbol
- HALO
- CIK
- 0001159036
Insider Information
- Name
- Torley Helen
- Role
- PRESIDENT AND CEO, Director
- Location
- SAN DIEGO, CA
DirectorOfficer
Filing Details
- Filing Date
- Feb 17, 2026
- Transaction Date
- Feb 16, 2026
- Accession Number
- 0001159036-26-000025
- Form Type
- 4
Non-Derivative Transactions
| Date | Security | Shares | Price | Type | Value |
|---|---|---|---|---|---|
| Feb 16, 2026 | Common Stock | 21,009 | — | Exercise | — |
| Feb 16, 2026 | Common Stock | 11,334 | $79.44 | Tax Withholding | $900.4K |
| Feb 16, 2026 | Common Stock | 16,875 | — | Exercise | — |
| Feb 16, 2026 | Common Stock | 9,104 | $79.44 | Tax Withholding | $723.2K |
| Feb 16, 2026 | Common Stock | 51,171 | — | Exercise | — |
| Feb 16, 2026 | Common Stock | 27,605 | $79.44 | Tax Withholding | $2.2M |
Derivative Transactions
| Date | Security | Shares | Exercise Price | Type | Value |
|---|---|---|---|---|---|
| Feb 16, 2026 | Derivative | 21,009 | — | Exercise | — |
| Feb 16, 2026 | Derivative | 16,875 | — | Exercise | — |
| Feb 16, 2026 | Derivative | 51,171 | — | Exercise | — |
Footnotes
- (F1)The reported disposition of 11,334 shares represents the shares that were withheld by the issuer as payment for tax withholding obligations.
- (F2)The reported disposition of 9,104 shares represents the shares that were withheld by the issuer as payment for tax withholding obligations.
- (F3)The reported disposition of 27,605 shares represents the shares that were withheld by the issuer as payment for tax withholding obligations.
- (F4)This transaction represents the vesting and settlement of restricted stock units in shares of common stock of the issuer.
- (F5)This transaction represents the vesting and settlement of performance stock units in shares of common stock of the issuer.